Malignant diverticulitis of the left colon complicating heart transplantation.
BACKGROUND
Colonic diverticular disease is rare in developing nations but common in Western and industrialized societies. Many studies show that heart and lung transplantation increase the risk of having severe diverticulitis, although the exact magnitude of this risk remain unclear because many of these studies have been small with short follow up. The term malignant diverticulitis has been employed to describe an extreme form of colon diverticulitis that is characterized by an extensive phlegmon and inflammatory reaction extending below the peritoneal reflection, with a tendency toward obstruction and fistula formation.


METHODS
We report a 57-year-old male, transplanted in our Institute for dilated cardiomyopathy due to previous myocardial ischemia, in whom, during the post-transplantation period, a malignant diverticulitis requiring an aggressive surgical approach was diagnosed, the diagnosis of diverticulosis was made during a colonoscopy in a pre-transplant work-up.


CONCLUSIONS
Immunosuppressed patients should be considered at high risk for developing a complicated malignant diverticular disease, and when diagnosed in a pre-transplant work-up, should be managed aggressively in terms of surgical approach when symptoms and signs suggest a diverticulitis.
Pagano
Duilio
D
Department of Abdominal and Transplantation Surgery, Mediterranean Institute for Transplantation and Advanced Specialized Therapies, University of Pittsburgh Medical Center in Italy, Palermo, Italy. dpagano@ismett.edu
Cintorino
Davide
D
Gruttadauria
Salvatore
S
Spada
Marco
M
Echeverri
Gabriel
G
Botrugno
Ivan
I
di Francesco
Fabrizio
F
Li Petri
Sergio
S
Gridelli
Bruno
B
D044683:Colon, Descending / Q000473:pathology / Q000601:surgery; D003113:Colonoscopy; D004239:Diverticulitis, Colonic / Q000175:diagnosis / Q000209:etiology* / Q000601:surgery; D043963:Diverticulosis, Colonic / Q000150:complications / Q000601:surgery; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome